elephas.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /_hcms/preview/ Disallow: | ||
Meta Tags
| Title | About | |
| Description | Elephas is a live tumor imaging company developing novel cancer diagnostic solutions to predict treatment outcomes and accelerate drug |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 99.83.248.72 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
elephas.com Valuation
|
US$10,167,351
Last updated: 2023-05-16 18:37:08
elephas.com has Semrush global rank of 1,041,009. elephas.com has an estimated worth of US$ 10,167,351, based on its estimated Ads revenue. elephas.com receives approximately 1,173,156 unique visitors each day. Its web server is located in United States, with IP address 99.83.248.72. According to SiteAdvisor, elephas.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$10,167,351 |
| Daily Ads Revenue | US$9,386 |
| Monthly Ads Revenue | US$281,558 |
| Yearly Ads Revenue | US$3,378,689 |
| Daily Unique Visitors | 78,211 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| elephas.com. | A | 180 | IP: 99.83.248.72 |
| elephas.com. | A | 180 | IP: 75.2.0.44 |
| elephas.com. | NS | 180 | NS Record: ns2.hosting.co.kr. |
| elephas.com. | NS | 180 | NS Record: ns1.hosting.co.kr. |
HtmlToTextCheckTime:2023-05-16 18:37:08
| about leadership investors board of directors join biopharma services powered by cybrid ™ clinical trials contact news & resources press releases media posters publications ELEPHAS MISSION To develop innovative cancer diagnostic products and services that enable accurate prediction of clinical treatment outcomes and accelerate drug development Biopharma Services Powered by Cybrid Clinical Trials News & Resources About Elephas Cancer is a leading cause of death worldwide, with the number of patients projected to triple by 2060. Despite recent advances in precision medicine and a significant increase in the number of available therapies, only 1 in 3 patients receiving therapy respond. Elephas is solving this problem by developing a technology suite to assess how human live tumor fragments (hLTF)™ respond to cancer therapies. We are removing the trial-and-error approach to cancer care by harnessing the latest advances in cancer biology, multimodal microscopy, and artificial intelligence |
HTTP Headers
HTTP/1.1 200 Date: Sun, 06 Feb 2022 11:20:05 GMT Content-Type: text/html;charset=UTF-8 Content-Length: 223 Connection: keep-alive Set-Cookie: visit_today=done; Max-Age=86400; Expires=Mon, 07-Feb-2022 11:20:05 GMT; HttpOnly X-Content-Type-Options: nosniff X-XSS-Protection: 1; mode=block Cache-Control: no-cache, no-store, max-age=0, must-revalidate Pragma: no-cache Expires: 0 Content-Language: en-US |
elephas.com Whois Information
Domain Name: ELEPHAS.COM Registry Domain ID: 86556357_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.hosting.kr Registrar URL: http://HOSTING.KR Updated Date: 2021-04-27T06:02:52Z Creation Date: 2002-05-14T07:01:17Z Registry Expiry Date: 2022-05-14T07:01:17Z Registrar: Megazone Corp., dba HOSTING.KR Registrar IANA ID: 1489 Registrar Abuse Contact Email: abuse@hosting.kr Registrar Abuse Contact Phone: +82.216447378 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.HOSTING.CO.KR Name Server: NS2.HOSTING.CO.KR DNSSEC: unsigned >>> Last update of whois database: 2022-02-06T08:10:55Z <<< |